were delivered with blood at ratios of 4:1 and subsequently at 4 to 8:1, depending on the arterial potassium concentration, and at a temperature of 22 to 28[degrees]C via both antegrade and retrograde techniques.
Objective: The aim of this study was to compare the effects of two different cardioplegic solutions
on nitric oxide (NO) release from coronary vasculature in patients with type II diabetes mellitus undergoing coronary artery bypass grafting (CABG) surgery.
The MPS system allows simpler, more flexible and cost-effective delivery of cardioplegic solutions
to the heart during open heart surgery.
The heart may arrest 2 |degrees~ to cold or as a result of various cardioplegic solutions
instilled at this time to achieve electromechanical arrest, placing the heart in a flaccid state.
Based upon what is known about the numerous cardioprotective effects of adenosine, we undertook this program to explore the possibility of modifying existing cardioplegic solutions
with the addition of adenosine in an attempt to potentially reduce myocardial stunning and improve patient outcomes.